Company
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen NewDEL Biotech, Co., Ltd has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ND-003 Tablets | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) |
Latest
No recent events.
Follow Shenzhen NewDEL Biotech, Co., Ltd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.